New selection
Safety of total daily doses of 5, 10, 15 and 20 mL PEG 400 administered orally to healthy male human subjects once (QD) or twice (BID) for 14 days. A single center, multiple rising dose study, placebo controlled, double-blinded at each dose level.
Download our Policy on Transparency and Publication of Clinical Study Data.Download
Browse our clinical study overview and read study synopses and lay summaries.
Learn about our process of responsible sharing of clinical study data and documents and request access to data and documents.
Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.
European Trial Register of EU studies.